FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/6/2026
Biohaven Pharma (NYSE: BHVN) CEO, Vlad Coric, bought 25,800 shares on 10/31/22 at $15.968.
The value of the purchase was $411,995.
Yesterday, Coric disclosed the purchase of $2.1 million in stock.
... More
